Copyright Reports & Markets. All rights reserved.

Global Clinical Biomarker Testing Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Clinical Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Cancer
    • 1.2.3 Metabolism
    • 1.2.4 Infectious Disease
    • 1.2.5 Cardiology
    • 1.2.6 Neurology
    • 1.2.7 Immunological Disease
  • 1.3 Market by Application
    • 1.3.1 Global Clinical Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Drug Discovery
    • 1.3.3 Nutrigenomics
    • 1.3.4 Toxicology Testing
    • 1.3.5 Personalized Medicine
    • 1.3.6 Functional Genomics
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Clinical Biomarker Testing Market Perspective (2016-2027)
  • 2.2 Clinical Biomarker Testing Growth Trends by Regions
    • 2.2.1 Clinical Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Clinical Biomarker Testing Historic Market Share by Regions (2016-2021)
    • 2.2.3 Clinical Biomarker Testing Forecasted Market Size by Regions (2022-2027)
  • 2.3 Clinical Biomarker Testing Industry Dynamic
    • 2.3.1 Clinical Biomarker Testing Market Trends
    • 2.3.2 Clinical Biomarker Testing Market Drivers
    • 2.3.3 Clinical Biomarker Testing Market Challenges
    • 2.3.4 Clinical Biomarker Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Clinical Biomarker Testing Players by Revenue
    • 3.1.1 Global Top Clinical Biomarker Testing Players by Revenue (2016-2021)
    • 3.1.2 Global Clinical Biomarker Testing Revenue Market Share by Players (2016-2021)
  • 3.2 Global Clinical Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Clinical Biomarker Testing Revenue
  • 3.4 Global Clinical Biomarker Testing Market Concentration Ratio
    • 3.4.1 Global Clinical Biomarker Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarker Testing Revenue in 2020
  • 3.5 Clinical Biomarker Testing Key Players Head office and Area Served
  • 3.6 Key Players Clinical Biomarker Testing Product Solution and Service
  • 3.7 Date of Enter into Clinical Biomarker Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Clinical Biomarker Testing Breakdown Data by Type

  • 4.1 Global Clinical Biomarker Testing Historic Market Size by Type (2016-2021)
  • 4.2 Global Clinical Biomarker Testing Forecasted Market Size by Type (2022-2027)

5 Clinical Biomarker Testing Breakdown Data by Application

  • 5.1 Global Clinical Biomarker Testing Historic Market Size by Application (2016-2021)
  • 5.2 Global Clinical Biomarker Testing Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Clinical Biomarker Testing Market Size (2016-2027)
  • 6.2 North America Clinical Biomarker Testing Market Size by Type
    • 6.2.1 North America Clinical Biomarker Testing Market Size by Type (2016-2021)
    • 6.2.2 North America Clinical Biomarker Testing Market Size by Type (2022-2027)
    • 6.2.3 North America Clinical Biomarker Testing Market Size by Type (2016-2027)
  • 6.3 North America Clinical Biomarker Testing Market Size by Application
    • 6.3.1 North America Clinical Biomarker Testing Market Size by Application (2016-2021)
    • 6.3.2 North America Clinical Biomarker Testing Market Size by Application (2022-2027)
    • 6.3.3 North America Clinical Biomarker Testing Market Size by Application (2016-2027)
  • 6.4 North America Clinical Biomarker Testing Market Size by Country
    • 6.4.1 North America Clinical Biomarker Testing Market Size by Country (2016-2021)
    • 6.4.2 North America Clinical Biomarker Testing Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Clinical Biomarker Testing Market Size (2016-2027)
  • 7.2 Europe Clinical Biomarker Testing Market Size by Type
    • 7.2.1 Europe Clinical Biomarker Testing Market Size by Type (2016-2021)
    • 7.2.2 Europe Clinical Biomarker Testing Market Size by Type (2022-2027)
    • 7.2.3 Europe Clinical Biomarker Testing Market Size by Type (2016-2027)
  • 7.3 Europe Clinical Biomarker Testing Market Size by Application
    • 7.3.1 Europe Clinical Biomarker Testing Market Size by Application (2016-2021)
    • 7.3.2 Europe Clinical Biomarker Testing Market Size by Application (2022-2027)
    • 7.3.3 Europe Clinical Biomarker Testing Market Size by Application (2016-2027)
  • 7.4 Europe Clinical Biomarker Testing Market Size by Country
    • 7.4.1 Europe Clinical Biomarker Testing Market Size by Country (2016-2021)
    • 7.4.2 Europe Clinical Biomarker Testing Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Clinical Biomarker Testing Market Size (2016-2027)
  • 8.2 Asia-Pacific Clinical Biomarker Testing Market Size by Type
    • 8.2.1 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Clinical Biomarker Testing Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Clinical Biomarker Testing Market Size by Application
    • 8.3.1 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Clinical Biomarker Testing Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Clinical Biomarker Testing Market Size by Region
    • 8.4.1 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Clinical Biomarker Testing Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Clinical Biomarker Testing Market Size (2016-2027)
  • 9.2 Latin America Clinical Biomarker Testing Market Size by Type
    • 9.2.1 Latin America Clinical Biomarker Testing Market Size by Type (2016-2021)
    • 9.2.2 Latin America Clinical Biomarker Testing Market Size by Type (2022-2027)
    • 9.2.3 Latin America Clinical Biomarker Testing Market Size by Type (2016-2027)
  • 9.3 Latin America Clinical Biomarker Testing Market Size by Application
    • 9.3.1 Latin America Clinical Biomarker Testing Market Size by Application (2016-2021)
    • 9.3.2 Latin America Clinical Biomarker Testing Market Size by Application (2022-2027)
    • 9.3.3 Latin America Clinical Biomarker Testing Market Size by Application (2016-2027)
  • 9.4 Latin America Clinical Biomarker Testing Market Size by Country
    • 9.4.1 Latin America Clinical Biomarker Testing Market Size by Country (2016-2021)
    • 9.4.2 Latin America Clinical Biomarker Testing Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Clinical Biomarker Testing Market Size (2016-2027)
  • 10.2 Middle East & Africa Clinical Biomarker Testing Market Size by Type
    • 10.2.1 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Clinical Biomarker Testing Market Size by Application
    • 10.3.1 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Clinical Biomarker Testing Market Size by Country
    • 10.4.1 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Clinical Biomarker Testing Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Clinical Biomarker Testing Introduction
    • 11.1.4 Abbott Laboratories Revenue in Clinical Biomarker Testing Business (2016-2021)
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 AbbVie Inc.
    • 11.2.1 AbbVie Inc. Company Details
    • 11.2.2 AbbVie Inc. Business Overview
    • 11.2.3 AbbVie Inc. Clinical Biomarker Testing Introduction
    • 11.2.4 AbbVie Inc. Revenue in Clinical Biomarker Testing Business (2016-2021)
    • 11.2.5 AbbVie Inc. Recent Development
  • 11.3 Adaptive Biotechnologies
    • 11.3.1 Adaptive Biotechnologies Company Details
    • 11.3.2 Adaptive Biotechnologies Business Overview
    • 11.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Introduction
    • 11.3.4 Adaptive Biotechnologies Revenue in Clinical Biomarker Testing Business (2016-2021)
    • 11.3.5 Adaptive Biotechnologies Recent Development
  • 11.4 Agilent Technologies
    • 11.4.1 Agilent Technologies Company Details
    • 11.4.2 Agilent Technologies Business Overview
    • 11.4.3 Agilent Technologies Clinical Biomarker Testing Introduction
    • 11.4.4 Agilent Technologies Revenue in Clinical Biomarker Testing Business (2016-2021)
    • 11.4.5 Agilent Technologies Recent Development
  • 11.5 BD
    • 11.5.1 BD Company Details
    • 11.5.2 BD Business Overview
    • 11.5.3 BD Clinical Biomarker Testing Introduction
    • 11.5.4 BD Revenue in Clinical Biomarker Testing Business (2016-2021)
    • 11.5.5 BD Recent Development
  • 11.6 Becton Dickinson
    • 11.6.1 Becton Dickinson Company Details
    • 11.6.2 Becton Dickinson Business Overview
    • 11.6.3 Becton Dickinson Clinical Biomarker Testing Introduction
    • 11.6.4 Becton Dickinson Revenue in Clinical Biomarker Testing Business (2016-2021)
    • 11.6.5 Becton Dickinson Recent Development
  • 11.7 Bio-Rad Laboratories
    • 11.7.1 Bio-Rad Laboratories Company Details
    • 11.7.2 Bio-Rad Laboratories Business Overview
    • 11.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Introduction
    • 11.7.4 Bio-Rad Laboratories Revenue in Clinical Biomarker Testing Business (2016-2021)
    • 11.7.5 Bio-Rad Laboratories Recent Development
  • 11.8 Danaher Corporation
    • 11.8.1 Danaher Corporation Company Details
    • 11.8.2 Danaher Corporation Business Overview
    • 11.8.3 Danaher Corporation Clinical Biomarker Testing Introduction
    • 11.8.4 Danaher Corporation Revenue in Clinical Biomarker Testing Business (2016-2021)
    • 11.8.5 Danaher Corporation Recent Development
  • 11.9 Merck and Co.
    • 11.9.1 Merck and Co. Company Details
    • 11.9.2 Merck and Co. Business Overview
    • 11.9.3 Merck and Co. Clinical Biomarker Testing Introduction
    • 11.9.4 Merck and Co. Revenue in Clinical Biomarker Testing Business (2016-2021)
    • 11.9.5 Merck and Co. Recent Development
  • 11.10 Thermofisher Scientific
    • 11.10.1 Thermofisher Scientific Company Details
    • 11.10.2 Thermofisher Scientific Business Overview
    • 11.10.3 Thermofisher Scientific Clinical Biomarker Testing Introduction
    • 11.10.4 Thermofisher Scientific Revenue in Clinical Biomarker Testing Business (2016-2021)
    • 11.10.5 Thermofisher Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Clinical Biomarker Testing Scope and Market Size
    Clinical Biomarker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Cancer
    Metabolism
    Infectious Disease
    Cardiology
    Neurology
    Immunological Disease

    Segment by Application
    Drug Discovery
    Nutrigenomics
    Toxicology Testing
    Personalized Medicine
    Functional Genomics

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Abbott Laboratories
    AbbVie Inc.
    Adaptive Biotechnologies
    Agilent Technologies
    BD
    Becton Dickinson
    Bio-Rad Laboratories
    Danaher Corporation
    Merck and Co.
    Thermofisher Scientific

    Buy now